1-(β-D-Arabinofuranosyl)cytosine 5'-monophosphate
CAS: 7075-11-8
Ref. 3D-NA10080
1g | 4.284,00 € | ||
50mg | 348,00 € | ||
100mg | 544,00 € | ||
250mg | 1.160,00 € | ||
500mg | 1.623,00 € |
Produktinformation
- Cytosine β-D-arabinofuranoside 5'-monophosphateCytarabine 5'-MonophosphateAra-CMP
- Ara-5'-CMP
- 1-beta-D-Arabinofuranosylcytosine 5'-monophosphate
- 1-beta-D-Arabinofuranosylcytosine 5'-phosphate
- 1beta-Arabino-furanosylcytosine-5'-monophosphoric acid, D-
- Arabinosylcytosine 5'-monophosphate
- Aracytidine 5'-monophosphate
- Aracytidine 5'-phosphate
- Cytarabine 5'-monophosphate
- Cytosine arabinoside 5'-monophosphate
- Mehr Synonyme anzeigen
- Cytosine arabinoside 5'-phosphate
- Cytosine arabinoside 5'MP
- Cytosine arabinoside monophosphate
- Nsc 99445
- 2(1H)-Pyrimidinone, 4-amino-1-(5-O-phosphono-beta-D-arabinofuranosyl)-
- Cytosine, 1-beta-D-arabinofuranosyl-, 5'-(dihydrogen phosphate) (8CI)
- 4-amino-1-(5-O-phosphono-beta-D-arabinofuranosyl)pyrimidin-2(1H)-one
- 1-β-D-Arabinofuranosylcytosine 5'-monophosphate
1-(β-D-arabinofuranosyl)cytosine 5'-monophosphate (AraCMP) is a nucleoside analog that inhibits DNA polymerase. It has been shown to be more potent than other analogs in a human serum model system, and synergistic with the matrix effect in cells. AraCMP also inhibits DNA synthesis by binding to the template strand of DNA and preventing it from being copied into RNA. In vivo models have shown that this drug can cause cell lysis and polymerase chain reactions (PCRs). Titration calorimetry data has revealed that AraCMP binds to the enzyme at a site near the active site where ATP hydrolysis occurs.
Chemische Eigenschaften
Technische Anfrage zu: 3D-NA10080 1-(β-D-Arabinofuranosyl)cytosine 5'-monophosphate
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.